However in our study, CD4+ CAR-T cells did not secrete enhanced levels of IL-2 (Supplementary Figure 3A) upon exposure to glioma cells and failed to improve the therapeutic efficacy of CAR-NK cells. The gene discussed is IL2; the disease is glioma.